NO20024838L - Salter av bicykliske, N-acylerte imidazo-3-aminer og imidazo- 5-aminer - Google Patents

Salter av bicykliske, N-acylerte imidazo-3-aminer og imidazo- 5-aminer

Info

Publication number
NO20024838L
NO20024838L NO20024838A NO20024838A NO20024838L NO 20024838 L NO20024838 L NO 20024838L NO 20024838 A NO20024838 A NO 20024838A NO 20024838 A NO20024838 A NO 20024838A NO 20024838 L NO20024838 L NO 20024838L
Authority
NO
Norway
Prior art keywords
amines
imidazo
bicyclic
salts
acylated
Prior art date
Application number
NO20024838A
Other languages
English (en)
Other versions
NO20024838D0 (no
NO323542B1 (no
Inventor
Matthias Gerlach
Corinna Maul
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of NO20024838D0 publication Critical patent/NO20024838D0/no
Publication of NO20024838L publication Critical patent/NO20024838L/no
Publication of NO323542B1 publication Critical patent/NO323542B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Addiction (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20024838A 2000-04-20 2002-10-07 Salter av bicykliske, N-acylerte imidazo-3-aminer og imidazo-5-aminer, fremgangsmate for fremstilling derav, deres anvendelse for fremstilling avlegemidler, samt legemidler inneholdende forbindelsene. NO323542B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10019714A DE10019714A1 (de) 2000-04-20 2000-04-20 Salze von bicyclischen, N-acylierten Imidazo-3-aminen und Imidazo-5-aminen
PCT/EP2001/003772 WO2001081344A1 (de) 2000-04-20 2001-04-03 Salze von bicyclischen, n-acylierten imidazo-3-aminen und imidazo-5-aminen

Publications (3)

Publication Number Publication Date
NO20024838D0 NO20024838D0 (no) 2002-10-07
NO20024838L true NO20024838L (no) 2002-10-07
NO323542B1 NO323542B1 (no) 2007-06-11

Family

ID=7639529

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024838A NO323542B1 (no) 2000-04-20 2002-10-07 Salter av bicykliske, N-acylerte imidazo-3-aminer og imidazo-5-aminer, fremgangsmate for fremstilling derav, deres anvendelse for fremstilling avlegemidler, samt legemidler inneholdende forbindelsene.

Country Status (30)

Country Link
US (2) US7087607B2 (no)
EP (1) EP1274709B1 (no)
JP (1) JP2003531208A (no)
KR (1) KR100756594B1 (no)
CN (1) CN1232520C (no)
AR (1) AR030559A1 (no)
AT (1) ATE277045T1 (no)
AU (2) AU2001258305B2 (no)
BR (1) BR0110357A (no)
CA (1) CA2402808A1 (no)
CZ (1) CZ20023476A3 (no)
DE (2) DE10019714A1 (no)
DK (1) DK1274709T3 (no)
ES (1) ES2227186T3 (no)
HK (1) HK1052703B (no)
HU (1) HUP0300532A3 (no)
IL (2) IL152352A0 (no)
MX (1) MXPA02009602A (no)
NO (1) NO323542B1 (no)
NZ (1) NZ521069A (no)
PE (1) PE20011213A1 (no)
PL (1) PL365676A1 (no)
PT (1) PT1274709E (no)
RU (1) RU2268888C2 (no)
SI (1) SI1274709T1 (no)
SK (1) SK15022002A3 (no)
TR (1) TR200402755T4 (no)
UY (1) UY26675A1 (no)
WO (1) WO2001081344A1 (no)
ZA (1) ZA200209408B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10019714A1 (de) 2000-04-20 2002-01-10 Gruenenthal Gmbh Salze von bicyclischen, N-acylierten Imidazo-3-aminen und Imidazo-5-aminen
DE10050663A1 (de) † 2000-10-13 2002-04-18 Gruenenthal Gmbh Verwendung von substituierten Imidazo[1,2-a]pyridin-, -pyrimidin- und pyrazin-3-yl-amin-Derivaten zur Herstellung von Medikamenten zur NOS-Inhibierung
EP1902056A2 (en) 2005-05-20 2008-03-26 Array Biopharma, Inc. Raf inhibitor compounds and methods of use thereof
TW200800213A (en) 2005-09-02 2008-01-01 Abbott Lab Novel imidazo based heterocycles
EP3417912B1 (en) 2005-12-23 2020-08-12 ARIAD Pharmaceuticals, Inc. Bicyclic heteroaryl compounds
MX2008011684A (es) 2006-03-17 2008-12-12 Ambit Biosciences Corp Compuestos de imidazolotiazol para el tratamiento de enfermedad.
WO2007138072A2 (en) * 2006-05-31 2007-12-06 Galapagos N.V. Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases
US7790741B2 (en) * 2006-10-06 2010-09-07 Abbott Laboratories Imidazothiazoles and imidazoxazoles
US8703492B2 (en) 2007-04-06 2014-04-22 Qiagen Gaithersburg, Inc. Open platform hybrid manual-automated sample processing system
US7985375B2 (en) * 2007-04-06 2011-07-26 Qiagen Gaithersburg, Inc. Sample preparation system and method for processing clinical specimens
KR101572701B1 (ko) * 2007-09-19 2015-11-27 암비트 바이오사이언시즈 코포레이션 Ｎ-(5-ｔｅｒｔ-부틸-이속사졸-3-일)-Ｎ'-[4-[7-(2-모르폴린-4-일-에톡시)이미다조[2,1-Ｂ][1,3]벤조티아졸-2-일]페닐]우레아를 포함하는 고체 형태, 그의 조성물 및 그의 용도
WO2011063139A1 (en) 2009-11-18 2011-05-26 Qiagen Laboratory central control unit method and system
KR200453430Y1 (ko) * 2011-01-10 2011-05-03 백현숙 싱크대용 선반
BR112014026643B1 (pt) 2012-04-26 2023-03-07 Universite De Montreal Derivados de imidazotiadiazol e imidazopirazina como inibidores de receptor 4 ativado por protease (par4) para o tratamento de agregação de plaqueta, seus usos e composição farmacêutica
EP2855489B1 (en) 2012-04-26 2017-01-04 Bristol-Myers Squibb Company Imidazothiadiazole and imidazopyridazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
KR20150003767A (ko) 2012-04-26 2015-01-09 브리스톨-마이어스 스큅 컴퍼니 혈소판 응집을 치료하기 위한 프로테아제 활성화 수용체 4 (par4) 억제제로서의 이미다조티아디아졸 유도체
US9598419B1 (en) 2014-06-24 2017-03-21 Universite De Montreal Imidazotriazine and imidazodiazine compounds
US9617279B1 (en) 2014-06-24 2017-04-11 Bristol-Myers Squibb Company Imidazooxadiazole compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2857776A (en) 1955-01-13 1958-10-28 American Metal Prod Lead screw selectively operable and releasable under load
US3489755A (en) 1966-08-03 1970-01-13 Pfizer & Co C Imidazo (1,2-b) pyridazines
US3792166A (en) * 1970-11-16 1974-02-12 American Cyanamid Co Method of using substituted imidazo (2,1-b)thiazoles as anthelmintic agents
US3894022A (en) * 1973-06-25 1975-07-08 Sandoz Ag Tetracyclic quinazolinones and quinazolinium salts
JPS5398997A (en) * 1977-02-09 1978-08-29 Sumitomo Chem Co Ltd Fused pyridine derivertives and process for their preparation
GB2039882A (en) * 1979-01-05 1980-08-20 Ciba Geigy Ag Bicyclic thiadiaza compounds and their use as medicaments
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
FR2568880B1 (fr) * 1984-08-07 1986-12-12 Synthelabo Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique
FR2627491B1 (fr) 1988-02-18 1992-01-24 Roussel Uclaf Nouveaux derives du benzocyclohexane et du benzocycloheptane ainsi que leurs sels, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et les compositions les renfermant
JPH0753730B2 (ja) * 1988-07-26 1995-06-07 三共株式会社 イミダゾピラゾール誘導体
US5536853A (en) * 1994-04-11 1996-07-16 Chiron Corporation Opiate receptor ligands
DE10019714A1 (de) 2000-04-20 2002-01-10 Gruenenthal Gmbh Salze von bicyclischen, N-acylierten Imidazo-3-aminen und Imidazo-5-aminen

Also Published As

Publication number Publication date
JP2003531208A (ja) 2003-10-21
HUP0300532A2 (hu) 2003-07-28
PL365676A1 (en) 2005-01-10
NO20024838D0 (no) 2002-10-07
PT1274709E (pt) 2005-01-31
AR030559A1 (es) 2003-08-27
ZA200209408B (en) 2004-02-19
TR200402755T4 (tr) 2004-12-21
WO2001081344A1 (de) 2001-11-01
NO323542B1 (no) 2007-06-11
HK1052703B (zh) 2005-04-22
US7153873B2 (en) 2006-12-26
US20030119842A1 (en) 2003-06-26
HK1052703A1 (en) 2003-09-26
EP1274709B1 (de) 2004-09-22
CN1422270A (zh) 2003-06-04
CA2402808A1 (en) 2001-11-01
EP1274709A1 (de) 2003-01-15
DE50103764D1 (de) 2004-10-28
BR0110357A (pt) 2004-04-20
AU2001258305B2 (en) 2005-08-18
KR20020087497A (ko) 2002-11-22
ES2227186T3 (es) 2005-04-01
HUP0300532A3 (en) 2009-01-28
NZ521069A (en) 2004-07-30
IL152352A (en) 2009-09-22
US7087607B2 (en) 2006-08-08
UY26675A1 (es) 2001-05-31
SI1274709T1 (en) 2005-02-28
AU5830501A (en) 2001-11-07
RU2268888C2 (ru) 2006-01-27
MXPA02009602A (es) 2003-03-10
DK1274709T3 (da) 2004-07-12
PE20011213A1 (es) 2001-12-29
DE10019714A1 (de) 2002-01-10
CZ20023476A3 (cs) 2003-01-15
SK15022002A3 (sk) 2003-04-01
US20060217378A1 (en) 2006-09-28
CN1232520C (zh) 2005-12-21
RU2002130245A (ru) 2004-03-27
KR100756594B1 (ko) 2007-09-10
ATE277045T1 (de) 2004-10-15
IL152352A0 (en) 2003-05-29

Similar Documents

Publication Publication Date Title
NO20041975D0 (no) Bicyklisk oksopyridin og oksopyrimidinderivater
MXPA03006260A (es) Derivados de amina sustituidos y metodos de uso.
ATE548938T1 (de) Zahnbürste
ATE513491T1 (de) Zahnbürste
NO20024838L (no) Salter av bicykliske, N-acylerte imidazo-3-aminer og imidazo- 5-aminer
DK1423376T3 (da) Bicyklisk forbindelse, fremstilling og anvendelse deraf
NO20040353L (no) Ny terapeutsk metode
DE60208982D1 (de) Fussbad
NO20033854L (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
AU2001258305A1 (en) Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines
NO20041968L (no) Anvendelse av cystationin
DE60210813D1 (de) Zahnbürste
DK1392670T3 (da) Substituerede C-furan-2-yl-methylamin- og C-thiophen-2-yl-methylamin-derivater
ATE333439T1 (de) Pflanzenkläranlage
DE60219418D1 (de) Silanylphenole und -naphthole
DE60228736D1 (de) Menschliches bmcc1-gen
DE60201822D1 (de) Sterilisierverfahren
FR2825913B1 (fr) Stimulateur central hydro-dynamogene des membres inferieurs
NO20033586L (no) Tannbörste
ZA200305198B (en) Substituted amine derivatives and methods of use.
SE0104249D0 (sv) Method of treatment
ITMS20010006U1 (it) Trattamento criogenico antitarlo
SE0101566D0 (sv) Bettskena
FI20002756A0 (fi) Uusi hoitomenetelmä
FIU20010239U0 (fi) Savusauna

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees